I. Einf?hrung.- M?glichkeiten und Probleme der Diagnostik und Therapie des Endometriumkarzinoms.- II. Prognosefaktoren.- Histopathology of Endometrial Cancer.- ?strogen- und Progesteronrezeptoren beim Endometriumkarzinom.- Estrogen and Progestin Receptors in Relation to Conventional Prognosis Indicators in Endometrial Carcinomas.- Flow Cytometry in Invasive Endometrial Carcinoma.- Oncogenes in Endometrial Cancer: A Review of Information.- EGF Receptor (EGF-R) Analysis in Endometrial Carcinomas.- On Hereditary Factors in Endometrial Carcinoma.- III. Operatives Vorgehen.- Surgery for Endometrial Carcinoma.- Treatment of Clinical Early Endometrial Carcinoma; Indications for Lymphonodectomy.- IV. Radiotherapie.- Postoperative Vaginal Irradiation by High-Dose-Rate Cobalt Afterloading in Stage I Endometrial Cancer: Experience from the Norwegian Radium Hospital.- V. Hormontherapie.- Adjuvante Hormontherapie beim Endometriumkarzinom.- Palliative Hormonal Treatment in Endometrial Carcinoma.- VI. Chemotherapie.- Systemic Chemotherapy for Advanced or Recurrent Endometrial Cancer.Springer Book ArchivesDE